Gufic BioSciences Ltd (GUFICBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "293.00",
    "chg": 5.9,
    "chgp": "2.06%",
    "dir": 1,
    "prev_price": "287.10",
    "mcapval": "2,905.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE742B01025",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "74.53 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3974711",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GuficBioScience_technicaldot_3974711.png",
        "date": "2026-05-05 08:01:48",
        "description": "Gufic BioSciences Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend, as reflected in recent technical indicators. Despite a modest day gain of 2.51%, the stock’s broader technical signals present a complex picture, with some indicators suggesting mild bullishness while others remain bearish or neutral, underscoring the need for cautious investor appraisal."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-strong-sell-3972024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GuficBioScience_mojoScore_3972024.png",
        "date": "2026-05-01 10:10:42",
        "description": "Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-faces-bearish-momentum-amid-technical-downgrade-3967409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_technicaldot_3967409.png",
        "date": "2026-04-29 08:00:58",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Sell to Strong Sell as of 17 Nov 2025. Despite a modest weekly price gain, the stock’s broader technical indicators signal increasing bearish pressure, reflecting challenges in sustaining upward momentum amid sector headwinds and market volatility."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3956753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_technicaldot_3956753.png",
        "date": "2026-04-22 08:01:16",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating with a Mojo Score of 28.0, the stock’s technical indicators reveal nuanced trends that investors should carefully analyse amid ongoing market volatility."
      },
      {
        "title": "Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Indicator Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-faces-bearish-momentum-amid-technical-indicator-shifts-3954930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_technicaldot_3954930.png",
        "date": "2026-04-21 08:01:49",
        "description": "Gufic BioSciences Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent performance, combined with deteriorating moving averages and mixed signals from momentum oscillators, suggests increasing downside pressure amid a challenging market environment."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-strong-sell-3953701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_mojoScore_3953701.png",
        "date": "2026-04-20 10:11:11",
        "description": "Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-strong-sell-3939305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_mojoScore_3939305.png",
        "date": "2026-04-09 10:10:46",
        "description": "Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gufic BioSciences Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-sees-mixed-technical-signals-amid-mild-momentum-shift-3938531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GuficBioScience_technicaldot_3938531.png",
        "date": "2026-04-09 08:01:36",
        "description": "Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 4.74% rise in the stock price to ₹300.50 on 9 Apr 2026, the company’s overall technical and fundamental signals suggest caution for investors amid mixed momentum and sector challenges."
      },
      {
        "title": "Markets Rally, But Gufic BioSciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-falls-to-52-week-low-of-rs2675-amid-market-downturn-3925711",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GuficBioScience_priceRelatedfactors_3925711.png",
        "date": "2026-03-30 15:33:48",
        "description": "Despite a broader market rally, Gufic BioSciences Ltd has plunged to a fresh 52-week low of Rs 267.5 on 30 Mar 2026, extending its recent downtrend amid persistent financial headwinds and valuation concerns."
      }
    ],
    "total": 556,
    "sid": "338998",
    "stock_news_url": "https://www.marketsmojo.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Update On Further Investment In Selvax Pty Ltd.",
      "datetime": "29-Apr-2026",
      "details": "Update on further investment in Selvax Pty Ltd. is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Apr-2026",
      "details": "Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026 is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-05 08:01:48

Gufic BioSciences Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend, as reflected in recent technical indicators. Despite a modest day gain of 2.51%, the stock’s broader technical signals present a complex picture, with some indicators suggesting mild bullishness while others remain bearish or neutral, underscoring the need for cautious investor appraisal.

Read full news article

Gufic BioSciences Ltd is Rated Strong Sell

2026-05-01 10:10:42

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-04-29 08:00:58

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Sell to Strong Sell as of 17 Nov 2025. Despite a modest weekly price gain, the stock’s broader technical indicators signal increasing bearish pressure, reflecting challenges in sustaining upward momentum amid sector headwinds and market volatility.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-22 08:01:16

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade to a Strong Sell rating with a Mojo Score of 28.0, the stock’s technical indicators reveal nuanced trends that investors should carefully analyse amid ongoing market volatility.

Read full news article

Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

2026-04-21 08:01:49

Gufic BioSciences Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent performance, combined with deteriorating moving averages and mixed signals from momentum oscillators, suggests increasing downside pressure amid a challenging market environment.

Read full news article

Gufic BioSciences Ltd is Rated Strong Sell

2026-04-20 10:11:11

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Gufic BioSciences Ltd is Rated Strong Sell

2026-04-09 10:10:46

Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Gufic BioSciences Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

2026-04-09 08:01:36

Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 4.74% rise in the stock price to ₹300.50 on 9 Apr 2026, the company’s overall technical and fundamental signals suggest caution for investors amid mixed momentum and sector challenges.

Read full news article

Markets Rally, But Gufic BioSciences Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 15:33:48

Despite a broader market rally, Gufic BioSciences Ltd has plunged to a fresh 52-week low of Rs 267.5 on 30 Mar 2026, extending its recent downtrend amid persistent financial headwinds and valuation concerns.

Read full news article

View All News